{"id":"NCT02684006","sponsor":"Pfizer","briefTitle":"A Study of Avelumab With Axitinib Versus Sunitinib In Advanced Renal Cell Cancer (JAVELIN Renal 101)","officialTitle":"A PHASE 3, MULTINATIONAL, RANDOMIZED, OPEN-LABEL, PARALLEL-ARM STUDY OF AVELUMAB (MSB0010718C) IN COMBINATION WITH AXITINIB (INLYTA(REGISTERED)) VERSUS SUNITINIB (SUTENT(REGISTERED)) MONOTHERAPY IN THE FIRST-LINE TREATMENT OF PATIENTS WITH ADVANCED RENAL CELL CARCINOMA","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-03-23","primaryCompletion":"2023-08-31","completion":"2024-06-26","firstPosted":"2016-02-17","resultsPosted":"2024-10-29","lastUpdate":"2025-07-30"},"enrollment":886,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Renal Cell Cancer"],"interventions":[{"type":"DRUG","name":"Avelumab (MSB0010718C)","otherNames":[]},{"type":"DRUG","name":"Axitinib (AG-013736)","otherNames":["Inlyta"]},{"type":"DRUG","name":"Sunitinib","otherNames":["Sutent"]}],"arms":[{"label":"Avelumab in combination with axitinib","type":"EXPERIMENTAL"},{"label":"Sunitinib","type":"ACTIVE_COMPARATOR"}],"summary":"This is a phase 3 randomized trial evaluating the anti-tumor activity and safety of avelumab in combination with axitinib and of sunitinib monotherapy, administered as first-line treatment, in patients with advanced renal cell carcinoma","primaryOutcome":{"measure":"Progression Free Survival (PFS) as Assessed by Blinded Independent Central Review (BICR) in Programmed Death-Ligand 1 (PD-L1) Positive Participants","timeFrame":"From date of randomization to the first documentation of PD or death due to any cause or censoring date, whichever occurred first (maximum up to approximately 26 months)","effectByArm":[{"arm":"Avelumab + Axitinib","deltaMin":13.8,"sd":null},{"arm":"Sunitinib","deltaMin":7.2,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":6,"exclusionCount":9},"locations":{"siteCount":270,"countries":["United States","Australia","Austria","Belgium","Canada","Denmark","France","Germany","Hungary","Israel","Italy","Japan","Mexico","Netherlands","New Zealand","Romania","Russia","South Korea","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["39886142","37852850","37526095","37146227","37104931","35239416","35166465","33947608","33901870","32895571","32339648","30779531"],"seeAlso":["https://pmiform.com/clinical-trial-info-request?StudyID=B9991003"]},"adverseEventsSummary":{"seriousAny":{"events":231,"n":434},"commonTop":["Diarrhoea","Hypertension","Fatigue","Nausea","Palmar-plantar erythrodysaesthesia syndrome"]}}